1
|
Booth JP, Kennerly-Shah JM, Kelley LR, Capozzi D, Prescott HA, Soefje SA, Pace MB, Barbour SY, Tizon RF, DeVincenzo S, Carnes CA, Neidecker MV. Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network. J Oncol Pharm Pract 2023; 29:1907-1914. [PMID: 36803319 DOI: 10.1177/10781552231157660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Abstract
INTRODUCTION Prioritization and acuity tools have been leveraged to facilitate targeted and efficient clinical pharmacist interventions. However, there is a lack of established pharmacy-specific acuity factors in the ambulatory hematology/oncology setting. Therefore, National Comprehensive Cancer Network's Pharmacy Directors Forum conducted a survey to establish consensus on acuity factors associated with hematology/oncology patients that are high priority for ambulatory clinical pharmacist review. METHODS A three-round electronic Delphi survey was conducted. During the first round, respondents were asked an open-ended question to suggest acuity factors based on their expert opinion. Respondents were then asked in the second round to agree or disagree with the compiled acuity factors, in which those with ≥75% agreement were included in the third round. The final consensus was defined as a mean score ≥3.33 on a modified 4-point Likert scale (4 = strongly agree, 1 = strongly disagree) during the third round. RESULTS A total of 124 hematology/oncology clinical pharmacists completed the first round of the Delphi survey (invitation response rate, 36.7%), of which 103 completed the second round (response rate, 83.1%) and 84 the third round (response rate, 67.7%). A final consensus was achieved for 18 acuity factors. Acuity factors were identified in the following themes: antineoplastic regimen characteristics, drug interactions, organ dysfunction, pharmacogenomics, recent discharge, laboratory parameters, and treatment-related toxicities. CONCLUSIONS This Delphi panel of 124 clinical pharmacists achieved consensus on 18 acuity factors that would identify a hematology/oncology patient as a high priority for ambulatory clinical pharmacist review. The research team envisions incorporating these acuity factors into a pharmacy-specific electronic scoring tool.
Collapse
Affiliation(s)
- Jennifer P Booth
- Department of Pharmacy, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA
- The Ohio State University-College of Pharmacy, Columbus, OH, USA
| | - Julie M Kennerly-Shah
- Department of Pharmacy, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA
| | | | - Donna Capozzi
- Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | | | | | - Makala B Pace
- Department of Pharmacy, Huntsman Cancer Institute, Salt Lake City, UT, USA
| | - Sally Y Barbour
- Department of Pharmacy, Duke Cancer Institute, Durham, NC, USA
| | - Ricky F Tizon
- Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Sarah DeVincenzo
- Department of Pharmacy, National Comprehensive Cancer Network, Plymouth Meeting, PA, USA
| | - Cynthia A Carnes
- The Ohio State University-College of Pharmacy, Columbus, OH, USA
| | | |
Collapse
|
2
|
Van Dril E, Schumacher C. Considerations for best practices related to sodium-glucose cotransporter-2 inhibitors and serum potassium levels. Am J Health Syst Pharm 2021; 78:1367-1368. [PMID: 33764438 DOI: 10.1093/ajhp/zxab122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Elizabeth Van Dril
- Department of Pharmacy Practice University of Illinois at Chicago College of Pharmacy University of Illinois Hospital and Health Sciences System Chicago, IL, USA
| | - Christine Schumacher
- Department of Pharmacy Practice Midwestern University College of Pharmacy Downers Grove, IL, USA
- Advocate Medical Group Chicago, IL, USA
| |
Collapse
|
3
|
Pamulapati LG, Rochester-Eyeguokan CD, Pincus KJ. Updated best practice statements regarding sodium-glucose cotransporter 2 inhibitors and serum potassium levels. Am J Health Syst Pharm 2021; 78:1369-1370. [PMID: 33764389 DOI: 10.1093/ajhp/zxab124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Lauren G Pamulapati
- Department of Pharmacotherapy and Outcomes Science Virginia Commonwealth University School of Pharmacy Richmond, VA, USA
| | | | - Kathleen J Pincus
- Department of Pharmacy Practice and Science University of Maryland School of Pharmacy Baltimore, MD, USA
| |
Collapse
|